Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,070 | 0,096 | 13:03 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
18.06. | Ventripoint Diagnostics Ltd (2): Ventripoint hires Fournel for advisory services | 1 | Stockwatch | ||
17.06. | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics grants options | 4 | Stockwatch | ||
17.06. | Ventripoint Diagnostics Ltd.: Ventripoint Partners with Fournel Advisory | 2 | TheNewswire | ||
17.06. | Ventripoint Diagnostics Ltd.: Ventripoint Issues Option Grants and Reports Exercise of Options | 2 | TheNewswire | ||
28.05. | Ventripoint Diagnostics Ltd.: Ventripoint to Exhibit at the 58th Annual Meeting of the Association for European Paediatric and Congenital Cardiology | 1 | TheNewswire | ||
30.04. | Ventripoint Diagnostics Ltd (2): Ventripoint appoints Gall to business advisory board | 1 | Stockwatch | ||
30.04. | Ventripoint Diagnostics Ltd.: Ventripoint Expands Advisory Board with addition of Ultrasound AI Executive | 1 | TheNewswire | ||
11.04. | Ventripoint Diagnostics Ltd (2): Ventripoint to hold shareholder teleconference April 15 | 1 | Stockwatch | ||
VENTRIPOINT DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
10.04. | Ventripoint Diagnostics Ltd.: Ventripoint Provides Corporate Update and Announces Shareholder Teleconference | 1 | TheNewswire | ||
08.04. | Ventripoint Diagnostics Ltd (2): Ventripoint $500,000 debenture private placement | 1 | Stockwatch | ||
08.04. | Ventripoint Diagnostics Ltd (2): Ventripoint appoints Coutin to oversee clinical affairs | 2 | Stockwatch | ||
08.04. | Ventripoint Diagnostics Ltd.: Ventripoint Appoints Nicolas Coutin to Oversee Clinical Affairs | - | TheNewswire | ||
08.04. | Ventripoint Diagnostics Ltd (2): Ventripoint Diagnostics warrants extended | 1 | Stockwatch | ||
04.04. | Ventripoint Diagnostics Ltd (2): Ventripoint applies to extend 2.84 million warrants | 1 | Stockwatch | ||
03.04. | Ventripoint Diagnostics Ltd.: Ventripoint Makes Application to Amend Warrants | 1 | TheNewswire | ||
24.03. | Ventripoint Diagnostics Ltd (2): Ventripoint publishes white paper on AI use | 1 | Stockwatch | ||
24.03. | Ventripoint Diagnostics Ltd.: Ventripoint Diagnostics Publishes Whitepaper on the Use of AI in Whole-Heart Analysis | 4 | TheNewswire | ||
22.03. | Ventripoint Diagnostics Ltd (2): Ventripoint 5.97-million-share private placement | 3 | Stockwatch | ||
21.03. | Ventripoint Diagnostics Ltd (2): Ventripoint closes $500,000 private placement | 1 | Stockwatch | ||
21.03. | Ventripoint Diagnostics Ltd.: Ventripoint Announces Closing of $500,000 Non-Brokered Convertible Debenture Unit Private Placement | 4 | TheNewswire |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ATOSSA THERAPEUTICS | 0,745 | -2,49 % | Atossa Genetics Year-end 2024 slides: (Z)-endoxifen shows promise, expenses decline | ||
TANDEM DIABETES | 16,160 | -0,03 % | TNDM Stock Gains on t:slim X2's Compatibility With FreeStyle Libre 3 + | ||
NETRAMARK | 0,860 | +1,78 % | Die nächste Cashcow? Schnelle Prozente mit NetraMark, Moderna, BioNTech | Erinnern Sie sich noch an den Impfstoff-Wettlauf in der Corona-Zeit? Damals bestimmte das Duell zwischen BioNTech und Curevac auch das Geschehen an der Börse. Anleger der ersten Stunde machten schnell... ► Artikel lesen | |
VERU | 0,565 | +9,51 % | Veru Inc.: Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation | --During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study... ► Artikel lesen | |
MOLINA HEALTHCARE | 248,00 | -1,08 % | Aktienmarkt: Aktie von Molina Healthcare tritt auf der Stelle (270,6171 €) | An der US-amerikanischen Börse ist die Molina Healthcare-Aktie aktuell unauffällig. Zuletzt zahlten Investoren für das Wertpapier 307,90 US-Dollar. Wenig getan hat sich heute bislang beim Kurs von Molina... ► Artikel lesen | |
CLOVER HEALTH INVESTMENTS | 2,382 | +1,93 % | Canaccord Genuity Keeps Buy Rating on Clover Health (CLOV) | ||
COGNETIVITY NEUROSCIENCES | 0,015 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.06.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 02.06.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.06.2025ISIN NameCA19243C1005 COGNETIVITY... ► Artikel lesen | |
SHL TELEMEDICINE | - | - | SHL TELEMEDICINE LTD - 6-K, Report of foreign issuer | ||
SOMNIGROUP INTERNATIONAL | 56,00 | +0,90 % | Somnigroup extends CEO Thompson's contract through 2029 | ||
SINTX TECHNOLOGIES | 3,200 | +1,27 % | Sintx Technologies, Inc. - 8-K, Current Report | ||
SEMLER SCIENTIFIC | 33,200 | +0,61 % | Semler Scientific startet Großoffensive: 105.000 Bitcoin bis 2028 geplant | ||
NEURONETICS | 2,830 | -0,53 % | Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | MALVERN, Pa., June 19, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve... ► Artikel lesen | |
RELEVIUM | 0,013 | -100,00 % | Relevium Technologies Inc.: Relevium Technologies to be delisted from NEX | ||
SIEMENS HEALTHINEERS | 46,900 | +0,13 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
FRESENIUS | 42,590 | +0,95 % | Aktienmarkt: Fresenius SE & Co. KGaA-Aktie kann sich nicht behaupten (42,16 €) | Der Anteilsschein von Fresenius SE & Co. KGaA notiert am Mittwoch leichter. Die Aktie kostete zuletzt 42,16 Euro. Für Inhaber von Fresenius+Co KgaA ist der heutige Handelstag bisher nicht sonderlich... ► Artikel lesen |